Summary
The purpose of the present study was to investigate whether the time of day (24 h) at which carbamazepine is administered influences its pharmacokinetics in the rat. The pharmacokinetics of a single, 100 mg.kg−1 bodyweightper os, dose of carbamazepine were studied at four different fixed time points of a 24-hour period (i.e. 10.00, 16.00, 22.00 or 04.00 h) in Wistar AF-SPF adult male rats maintained under controled environmental conditions (LD: 18.00 – 06.00h) during October 1978. The total plasma levels and the unbound fraction were measured according to an immunoenzymatic method (EMIT). The effects of fasting were also investigated.
The data shows circadian variations of pharmacokinetic parameters: the maximum peak concentration and the maximum time to reach this peak was observed when the drug was given respectively at 16.00h and at 10.00h. The elimination half-life varied from 15.15 hours at I6.00h to 10.48 hours at 22.00h. The observed variations may be related to: daily fluctuations of absorption or binding of the drug; diurnal variations of the hepatic drug metabolizing enzymes responsible for the inactivation; and/or diurnal variations in excretion rate of the drug.
Similar content being viewed by others
References
Aymard N. and Soulairac A. (1979) — Chronobiologic changes in pharmacokinetics of dipotassic chlorazepate. 7 th int. Congr. Pharmacol., Symposium on Chronopharmacology, Paris-Velizy 22–24 july 1978, in Remberg A. and Halberg F. Eds.Chronopharmacology, Pergamon Press, Oxford-New York, pp 111–116.
Bouyard P., Bruguerolle B., Jadot G., Mesdjian E. and Valli M. (1974) — Mise en évidence d’un rythme nycthéméral dans le phénomène de la curarisation chez le rat.C.R. Soc. Biol., 168: 1005–1007.
Bruguerolle B., Mesdjian E., Valli M., Jadot G., Agopian B. and Bouyard P. (1977) — Etude chronopharmacologique du bromure de pancuronium chez le rat.J. Pharmacol. (Paris), 8: 49–58.
Bruguerolle B., Mesdjian E., Valli M., Blanc M.C., Jadot G., Vignon E. and Bouyard P. (1978) — Etude chronopharmacologique de l’alfatésine chez le rat mâle.J. Pharmacol. (Paris), 9: 53–64.
Bruguerolle B., Valli M., Rakoto J.C., Jadot G., Bouyard P. and Reinberg A. (1979) — Chronopharmacology of pancuronium in the rat: anaesthesia or sea sonal influence? 7 th int. Congr. Pharmacol. Symposium on Chronopharmacology, Paris-Vélizy 22–24 July 1978 in Reinberg A. and Halberg F. Eds., Chronopharmacology, Pergamon Press Oxford-New York, pp 117–123.
Carosella L., Di Nardo P., Bernabei R., Cocchi A., Di Gennaro M. and Carbonin P. (1979) — Chronopharmacokinetics of digitalis. Circadian variations of methyldigoxin serum levels after oral administration. 7 th int. Congr. Pharmacol., Symposium on Chronopharmacology, Paris-Vélizy 22–24 July 1978, in Reinberg A. and Halberg F. Eds.,Chronopharmacology, Pergamon Press Oxford-New York. pp 125–134.
Clench J., Reinberg A., Chata J. and Dupont J. (1975) — Chronopharmacokinetics of indomethacin in healthy young human subjects.Chronobiologia, 2: 14–15.
Cotter L.M., Eadie J.M., Hooper W.D., Lander C.M., Smith G.A. and Tyrer J.H. (1977) — The pharmacokinetics of carbamazepine.Europ. J. Clin. Pharmacol., 12: 451–456.
Gibaldi M. and Perrier D. (1975) — Pharmacokinetics. Dekker Ed., New York.
Hardeland R., Hohmann D. and Rensig L. (1973) — The rhythmic organization of rodent liver: a review.J. Interdiscipl. Cycle Res., 4: 89–118.
Jori A., Salle D. and Santini V. (197!) — Daily rhythmic variation and liver drug metabolism in rats.Biochem. Pharmacol., 20: 2965–2969.
Levy R.H. Pitlick W.H., Troupin A.S., Green J.M. and Neal J.M. (1975) Pharmacokinetic eraluation of carbanarepine in normal human volonters. Epilepsia, A6: 197–207.
Lockard J.S., Levy R.H., Du Charme L.L., Gongdon W.C. and Patel I.H. (1979) — Carbamazepine revisited in a monkey model.Epilepsia, 20: 169–173.
Markiewicz A., Semenowicz K., Korczynska J. and Czachowska A. (1979) — Chronopharmacokinetics of dipyridamole.Intern. J. Clin. Pharmacol. Biopharm. 17: 222–224.
Meinardi H. (1975) — Carbamazepine. In Woodbury D.M. et al. Eds.,Antiepileptic drugs. Raven Press, New York, pp 487–496.
Morselli P.L. (1975) — Carbamazepine: absorption, distribution and excretion. In Penry J.K. and Daly D.D. Eds.,Advances in Neurology: 11, Raven Press, New York, pp 279–293.
Morselli P.L., Biandrate P., Frigerio A. and Garattini S. (1972) — Pharmacokinetics of carbamazepine in rats and humans.Europ. J. Clin. Invest., 2: 297–306.
Morselli P.L., Gerna M. and Garanttini S. (1971) — Carbamazepine plasma and tissue levels in the rat.Biochem. Pharmacol., 20: 2043–2047.
Moore-Ede M.C. (1973) — Circadian rhythms of drug effectivness and toxicity.Clin. Pharmacol. Therap., 14: 925–935.
Nair V. and Casper R. (1969) — The influence of light on daily rhythm in the hepatic drug-metabolizing enzymes in rat.Life Sciences, 8: 1291–1298.
Peret J., Chanez M. and Pascal G. (1976) — Taux de protéines dans la ration alimentaire et variations circadiennes des activités enzymatiques impliquées dans le métabolisme des glucides et dans la lipogénèse chez le rat mâle.J. Physiol. (Paris), 72: 683–696.
Pynnonen S. (1977) — The pharmacokinetics of carbamazepine in plasma and saliva in man.Acta Pharmacol. Toxicol., 41: 465–471.
Razialowski F.M. and Bousquet W.F. (1968) — Daily rhythmic variation in hepatic drug metabolism in the rat and mouse.J. Pharmacol, exptl. Therap., 163: 229–238.
Reinberg A. and Halberg F. (1971) — Circadian pharmacology.Ann. Rev. Pharmacol., 11: 455–492.
Reinberg A., Clench J., Aymard N., Galliot M., Bourdon R., Gervais P., Abulker C. and Dupont J. (1975) — Variations circadiennes des effets de l’éthanol et de Péthanolémie chez l’homme sain. Etude chronopharmacologique.J. Physiol. (Paris), 70: 435–456.
Reinberg A., Clench J., Ghata J., Halberg F., Abulker C., Dupont J. and Zagulla-Mally Z. ( 1975) — Rythmes circadiens des paramètres de l’excrétion urinaire du salicylate (chronopharmacocinétique) chez l’homme adulte sain.CR. Ac. Sei. Paris, 280: 1697–1699.
Richter K. and Terhaag B. (1978) — The relative bioavaibility and pharmacokinetics of carbamazepine.Intern. J. Clin. Pharmacol., Biopharm., 16: 377–379.
Scheving L.E., Pauly S.E. and Hutsai T. (1968) — Circadian fluctuation in plasma proteins of the rat.Am. J. Physiol., 215: 1096–1101.
Scheving L.E., Mayersbach H. (von) and Pauly J.E. (1974) — An overview of chronopharmacology.Europ. J. Toxicol., 7: 203–227.
Shively C.A. and Vesell E.S. (1975) — Temporal variations in acetaminophen and phenacetin half-life in man.Clin. Pharmacol. Therap., 18: 413–424.
Strandjord R.E. and Johannessen S.I. (1975) — A preliminary study of serum carbamazepine levels in healthy subjects and in patients with epilepsy. In Schneider H. et al. (Eds.),Clinical Pharmacology of antiepileptic Drugs, Springer Verlag, Berlin-Heidelberg, pp 181–188.
Sturtevant F.M., Sturtevant R.P., Scheving L.E. and Pauly J.E. (1975) — Chronopharmacokinetics of ethanol in man.Chronobiologia, 2, supplt 1, 69.
Tredger J.M. and Chabra R.S. (1977) — Circadian variations in microsomal drug metabolizing enzyme activities in rat and rabbit tissues.Xenobiotica, 7: 481–489.
Valli M., Jadot G., Bruguerolle B., Bussiere H. and Bouyard P. (1979) — Variations circadiennes des protéines plasmatiques chez le rat mâle adulte en synchronisation naturelle.J Physiol. (Paris), 75: 811–814.
Vesell E.S., Shively C.A. and Passananti G.T. (1977) — Temporal variations of antipyrine half-life in man.Clin. Pharmacol. Therap., 22: 843–852.
Author information
Authors and Affiliations
Additional information
This work is dedicated to Prof. H. Gastaut for his accession to the Honorary-Chairmanship of the Aix-Marseille II University.
Rights and permissions
About this article
Cite this article
Bruguerolle, B., Valli, M., Bouyard, L. et al. Circadian effect on carbamazepine kinetics in rat. European Journal of Drug Metabolism and Pharmacokinetics 6, 189–193 (1981). https://doi.org/10.1007/BF03189488
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189488